Akero Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company…
53,630$
-0,33%
Echtzeit-Aktienkurs Akero Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Akero Therapeutics Inc. Aktie
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company…
Akero Therapeutics launches $300 million stock offering By Investing.com
Akero Therapeutics launches $300 million stock offering…
Akero Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company…
Akero Therapeutics reports positive EFX trial results By Investing.com
Akero Therapeutics reports positive EFX trial results…
Wall Street Analysts Predict a 58.87% Upside in Akero Therapeutics, Inc. (AKRO): Heres What You Should Know
The mean of analysts price targets for Akero Therapeutics, Inc. (AKRO) points to a 58.9% upside in the stock. While…